Evidence map›Paper›PMID 42056071›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.

Sandra Giménez, Lídia Vaqué-Alcázar, Susana Clos, Bessy Benejam, Maria Carmona-Iragui, Lucía Maure-Blesa, Laura Videla, Nuole Zhu, Miren Altuna, Javier Arranz and 17 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Sandra GiménezMultidisciplinary Sleep Unit, Respiratory Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant, Pau (IIB SANT PAU), Barcelona, Spain.ORCID https://orcid.org/0000-0001-8031-2319
Lídia Vaqué-AlcázarSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Susana ClosSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Bessy BenejamSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Maria Carmona-IraguiSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Lucía Maure-BlesaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Laura VidelaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Nuole ZhuSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Miren AltunaCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, Donostia-San Sebastián, Spain.
Javier ArranzSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Isabel BarroetaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Íñigo Rodríguez-BazSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Alexandre BejaninSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Ana BuenoSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Susana FernandezBarcelona Down Medical Center, Fundació Catalana de Síndrome de Down, Barcelona, Spain.
Laura Del Hoyo SorianoSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Lucia PertierraSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Daniel AlcoleaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Bruce MillerGlobal Brain Health Institute, University of California, San Francisco, California, USA.
Lea T GrinbergGlobal Brain Health Institute, University of California, San Francisco, California, USA.
Joaquin RuizDepartment of Psychiatry, New York University Langone Health, New York City, New York, USA.
Christos Panagiotis LisgarasDepartment of Psychiatry, New York University Langone Health, New York City, New York, USA.
Hau-Tieng WuDepartment of Mathematics at the Courant Institute of Mathematical Sciences, New York University, New York City, New York, USA.
Alberto LleóSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
Ricardo S OsorioDepartment of Psychiatry, New York University Langone Health, New York City, New York, USA.
Esther M BlessingDepartment of Psychiatry, New York University Langone Health, New York City, New York, USA.
Juan ForteaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI THOMAS M WISNIEWSKI · 2020 to 2026
$28.4M
Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's diseaseR01AG075802 · NIA · MAYO CLINIC JACKSONVILLE · PI BERNARDINO Francesco GHETTI, Lea Tenenholz Grinberg · 2022 to 2026
$15.5M
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSPU54NS123746 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRINBERG, LEA TENENHOLZ · 2021 to 2025
$9.4M
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSPR01AG060477 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Lea Tenenholz Grinberg, Thomas C Neylan · 2019 to 2026
$8.2M
DS-ARC: A Remote Digital Cognitive Assessment for Down Syndrome-Associated Alzheimer's DiseaseR01AG081394 · NIA · WASHINGTON UNIVERSITY · PI Jason J Hassenstab · 2023 to 2026
$6.0M
The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-RevisionRF1AG056850 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUSCIGLIO, JORGE A, CUELLO, A CLAUDIO · 2018 to 2020
$5.9M
Clinical trials to prevent Alzheimer's Disease in Down SyndromeR61AG066543 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RAFII, MICHAEL S · 2019 to 2020
$5.6M
Tau pathology in Down syndrome and Alzheimer'sRF1AG061566 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER, MARGITTAI, MARTIN · 2019 to 2019
$3.4M
Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal StudyRF1AG080769 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BLESSING, ESTHER MARIAN, FORTEA, JUAN · 2023 to 2023
$1.9M
Neuropathological changes underlying clinical heterogeneity in Alzheimer diseaseK24AG053435 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRINBERG, LEA TENENHOLZ · 2016 to 2025
$1.8M
Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal StudyR01AG080769 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Esther Marian Blessing, Juan Fortea · 2026 to 2026
$617k
High frequency oscillations in Alzheimer's diseaseR21AG086880 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI LISGARAS, CHRISTOS PANAGIOTIS · 2024 to 2024
$454k
Alzheimer's Association AARG-22-923680Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas PI20/00836CURE Epilepsy Grant #1466036European Union H2020-SC1-BHC-2018-2020Fondation Jérôme Lejeune (#1913 cycle 2019BFundació La Caixa 23S06157-001Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona 23S06157-001Fundación Tatiana Pérez de Guzmán el Bueno IIBSP-DOW-2020-151Global Brain Health Institute GBHI_ALZ-18-543740HORIZON EUROPE Framework Programme H2020-SC1-BHC-2018-2020Instituto de Salud Carlos IIIJérôme Lejeune Foundation 1801 Cycle 2020Jérôme Lejeune Foundation 1913 cycle 2019BJérôme Lejeune Foundation GBHI_ALZ-23-971107New York State Office of Mental HealthNIA NIH HHS K24 AG053435NIA NIH HHS P30 AG066512NIA NIH HHS R01 AG060477NIA NIH HHS R01 AG075802NIA NIH HHS R01 AG080769NIA NIH HHS R01 AG081394NIA NIH HHS R21 AG056974NIA NIH HHS R21 AG-086880NIA NIH HHS R21 AG086880NIA NIH HHS R21AG086880NIA NIH HHS R61 AG066543NIA NIH HHS RF1 AG056850NIA NIH HHS RF1 AG061566NIA NIH HHS RF1 AG080769NIH HHS 1RF1AG080769-01NIH HHS K24AG053435NIH HHS R01 AG056850NIH HHS R01 AG060477-01NIH HHS R01 AG061566NIH HHS R01 AG075802-04NIH HHS R01 AG081394NIH HHS R21 AG056974NIH HHS R61AG066543NIH HHS U54 NS123746NINDS NIH HHS U54 NS123746University of California Global Health Institute GBHI_ALZ-18-543740
6 · The paper itself

Abstract

introductionSleep and circadian rest-activity rhythm (RAR) disruption may bidirectionally relate to Alzheimer's disease (AD). Down syndrome (DS), the most common genetic cause of AD, presents sleep disorders, yet RAR patterns across the DS-associated AD continuum remain uncharacterized.

methodsWe analyzed 7-day wrist actigraphy in 140 adults with DS (108 asymptomatic; 32 AD dementia) and 41 unimpaired controls. General linear models, adjusted for age, sex, sleep efficiency, and obstructive sleep apnea (OSA) severity, tested group differences, with interaction terms included to evaluate group-specific associations.

resultsDS showed lower relative amplitude and higher nocturnal activity, already in asymptomatic individuals. Rhythm strength declined further with AD progression, while regularity and phase timing remained preserved until dementia. Findings were independent of sleep duration and OSA. DISCUSSION: Adults with DS showed early RAR disturbance that progressed across the AD continuum, paralleling sporadic AD. Circadian RAR features may be scalable biomarkers of AD progression.

Indexed as

Alzheimer DiseaseCircadian RhythmDown SyndromeRestActigraphyAdultAgedDisease ProgressionFemaleHumansMaleMiddle AgedactigraphyagingAlzheimer's diseasecircadian rest–activity rhythm patternsDown syndromesleep

Identifiers

PMID42056071
PMCPMC13128343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.